PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
18.62
+0.62 (3.44%)
Jul 31, 2026, 4:00 PM EDT - Market closed
PROCEPT BioRobotics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 322.02 | 308.05 | 224.5 | 136.19 | 75.01 | 34.47 | |
Revenue Growth | 29.26% | 37.22% | 64.84% | 81.55% | 117.60% | 346.72% |
Cost of Revenue | 116.01 | 111.83 | 87.4 | 65.14 | 37.93 | 18.61 |
Gross Profit | 206.01 | 196.23 | 137.1 | 71.05 | 37.09 | 15.87 |
Selling, General & Admin | 238.7 | 228.81 | 171.42 | 131.77 | 88.83 | 51.04 |
Research & Development | 76.34 | 71.28 | 62.3 | 48.45 | 28.98 | 18.99 |
Total Operating Expenses | 315.04 | 300.09 | 233.71 | 180.22 | 117.81 | 70.03 |
Operating Income | -109.03 | -103.86 | -96.61 | -109.17 | -80.72 | -54.16 |
Interest Income | 10.23 | 12.06 | 9.75 | 7.35 | 2.01 | 0.12 |
Interest Expense | -3.53 | -3.59 | -4.18 | -4 | -5.18 | -5.81 |
Other Non-Operating Income (Expense) | - | - | - | - | -3.26 | - |
Total Non-Operating Income (Expense) | 6.7 | 8.48 | 5.57 | 3.35 | -6.43 | -5.69 |
Pretax Income | -102.33 | -95.38 | -91.05 | -105.82 | -87.15 | -59.85 |
Provision for Income Taxes | - | 0.19 | 0.37 | 0.08 | - | - |
Net Income | -102.33 | -95.57 | -91.41 | -105.9 | -87.15 | -59.85 |
Net Income to Common | -102.47 | -95.57 | -91.41 | -105.9 | -87.15 | -59.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 56 | 56 | 52 | 47 | 44 | 16 |
Shares Outstanding (Diluted) | 56 | 56 | 52 | 47 | 44 | 16 |
Shares Change | 4.37% | 6.56% | 10.31% | 6.43% | 169.42% | 349.90% |
EPS (Basic) | -1.82 | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 |
EPS (Diluted) | -1.82 | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -80.57 | -58.34 | -103.62 | -133.21 | -83.04 | -57.93 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.44 | -1.05 | -1.99 | -2.82 | -1.87 | -3.51 |
Gross Margin | 63.97% | 63.70% | 61.07% | 52.17% | 49.44% | 46.02% |
Operating Margin | -33.86% | -33.71% | -43.04% | -80.16% | -107.61% | -157.12% |
Profit Margin | -31.78% | -31.02% | -40.72% | -77.76% | -116.18% | -173.62% |
FCF Margin | -25.02% | -18.94% | -46.16% | -97.81% | -110.69% | -168.03% |
EBITDA | -102.38 | -97.47 | -91.38 | -105.36 | -77.88 | -50.84 |
EBITDA Margin | -31.79% | -31.64% | -40.70% | -77.36% | -103.82% | -147.48% |
EBIT | -109.03 | -103.86 | -96.61 | -109.17 | -80.72 | -54.16 |
EBIT Margin | -33.86% | -33.71% | -43.04% | -80.16% | -107.61% | -157.12% |
Effective Tax Rate | - | -0.20% | -0.40% | -0.08% | 0.00% | 0.00% |